Visit the NEW CoM Homepage |  University of Kentucky |  UK HealthCare |  Give to Medicine |  Diversity  
UK College of Medicine logo Link to the College of Medicine web site
  • ed4
  • rs2
  • cs1
  • ad3

Emergency Medicine

NAVIGATION

HYPERBARIC OXYGEN TREATMENT (HBOT) SERVICE

The Department of Emergency Medicine directs the UK Hospital HBOT Service. The treatment facility is located adjacent to the Emergency Department. Dr Charles Eckerline Jr. is the medical director and, along with the other Emergency Medicine faculty, supervises patient treatment. LaDawn Reynolds, BA, RRT, is the full-time hyperbaric therapist and provides weekday scheduled patient treatments.

The HBOT service uses a Sechrist monoplace chamber capable of pressures to 3.0 ATA (atmospheres absolute or 66 psi). The chamber has the capability of cardiac rhythm monitoring, intravenous infusions, mechanical ventilation, and air breaks for patients undergoing treatment. The service provides scheduled treatments Monday through Friday, between 8:00 am and 4:00 pm. Emergency treatments are provided on an on-call basis. Currently, the program provides over 400 treatments per year.

The HBOT service follows the approved uses of hyperbaric treatment as developed by the Undersea and Hyperbaric Medical Society and the approved indications for hyperbaric treatment as established by Medicare. In these conditions, there is clinical evidence of benefit with HBOT. These conditions are:

  • Air or Gas Embolism
  • Arterial Insufficiencies
    • Central Retinal Artery Occlusion
    • Enhancement of Healing in Selected Problem Wounds
  • Carbon Monoxide Poisoning
  • Clostridial Myonecrosis (Gas Gangrene)
  • Compromised Grafts and Flaps
  • Crush Injuries and Skeletal Muscle-Compartment Syndrome
  • Decompression Sickness
  • Delayed Radiation Injuries (Soft Tissue and Bony Necrosis)
    • Mandibular Osteoradionecrosis
    • Soft Tissue Necrosis/Radiation Cystitis, Proctitis, Enteritis
  • Idiopathic Sudden Sensorineural Hearing Loss
  • lntracranial Abscess
  • Necrotizing Soft Tissue Infections
  • Refractory Osteomyelitis
  • Severe Anemia
  • Thermal Burns

It is the policy of the UK Hospital HBOT service that only patients with an accepted or approved indication will be treated. Treatment of patients for other reasons will only be done using an IRB approved research protocol.

The majority of scheduled patients treated by the UK HBOT service have either osteoradionecrosis or soft tissue radionecrosis and typically undergo 30 to 40 treatments over 6 to 8 weeks. Emergency patients are generally severe carbon monoxide intoxication and undergo 1 to 3 treatments. Most treatments last 90 to 120 minutes and utilize pressures of 2.5 to 3.0 ATA.

Absolute contraindications to HBOT include:

  1. Untreated pneumothorax
  2. Recent doxorubicin administration (within one week)
  3. Daily disulfiram treatment
  4. Current cis-plantinum therapy
  5. Current mafenide therapy

Relative contraindications to HBOT include:

  1. Current sinusitis
  2. Seizure disorder
  3. Emphysema with CO2 retention
  4. History of spontaneous pneumothorax
  5. History of surgery for otosclerosis
  6. History of optic neuritis

To refer a patient for potential HBOT:

  1. Routine referral for scheduled outpatients: call the department office at 859-323-5081 and request a HBOT consultation.
  2. Emergency referrals: call UKMDs at 859-231-9922 or 800-888-5533 and ask for the Emergency Department Attending.
Comments and Corrections |  An Equal Opportunity University |  Jobs  |  Terms, Conditions and Accessibility Statements   |  Privacy
© 2012, University of Kentucky College of Medicine, 138 Leader Ave., Lexington, Kentucky, USA 40506-9983
Student Affairs: (859) 323-5261 · Admissions: (859) 323-6161 · Clinical Questions: (859) 257-1000 · Dean's Office: (859) 323-6582
Page last updated Wednesday, May 25, 2016